P. Perini

Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants.

Rocco Piazza, Roberta Rostagno, Manuela Marega, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib

R. Rigolio, Mario Mauri, A. Giannoudis, 2015, Journal of Hematology & Oncology.

Role of the drug transporters in the multidrug resistance affecting bosutinib treatment

S. Redaelli, C. Gambacorti-Passerini, P. Perini, 2011 .

Reply to P. Laneuville et al

S. Redaelli, C. Gambacorti-Passerini, R. Piazza, 2010 .

Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib

S. Redaelli, C. Gambacorti-Passerini, F. Boschelli, 2010, Leukemia.